<?xml version="1.0" encoding="UTF-8"?> 
		<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
		  <channel>
		    <image>
			<title>patentstorm.us</title>
			<width>258</width>
			<height>85</height>
			<link>http://www.patentstorm.us/</link>
			<url>http://www.patentstorm.us/images/logo.gif</url>
			</image>
					
		    <title>PatentStorm ->  Applications -> Organic compounds -- part of the class 532-570 series</title>
		    <link>http://www.patentstorm.us/rss/class/applications/rss-548.xml</link>
		    <description>Recent patent applications filings in USPTO Class 548 Organic compounds -- part of the class 532-570 series.</description>
		    <pubDate>Thu, 16 May 2013 15:04:53</pubDate>
		    <managingEditor>patents@patentstorm.us</managingEditor>
		    <language>en</language><item>
			         <title><![CDATA[Imaging Agents]]></title>
			         <link>http://www.patentstorm.us/applications/20130123618/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123618</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;EMORY UNIVERSITY, </li></ul>This invention provides amino acid derivatives useful in detecting and evaluating brain and body tumors, including (1S,2S) anti-2-[<sup>18</sup>F]FACPC and (1R,2R) ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123618</guid>
			      </item>
<item>
			         <title><![CDATA[Adhesive Compositions for Bonding Composites]]></title>
			         <link>http://www.patentstorm.us/applications/20130123513/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123513</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Georgia-Pacific Chemicals LLC, </li></ul>The present invention relates to a non-thermosetting composition made by reacting epichlorohydrin and a primary amine, to the use of that composition for making thermosetting (curable) adhesives suitable for bonding composites, to a method of preparing composites using the thermosetting (curable) adhesives, and to the related composites bonded with the thermosetting (curable) ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123513</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES]]></title>
			         <link>http://www.patentstorm.us/applications/20130123512/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123512</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Hoffmann-La Roche Inc., </li></ul>The present invention relates in part to a process for the preparation of a proline derivative of formula I</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein,
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">
    <ul id="ul0002" list-style="none">
        <li id="ul0002-0001" num="0000">R<sup>1 </sup>is C<sub>1-7</sub>-alkyl or</li>
    </ul>
    </li>
</ul>
</p>
<p id="p-0004" num="0000">
<ul id="ul0003" list-style="none">
    <li id="ul0003-0001" ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123512</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE DIRECT PREPARATION OF MALIC ACID SALT OF SUNITINIB]]></title>
			         <link>http://www.patentstorm.us/applications/20130123511/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123511</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Sathyanarayana, Swargam; Prasad, Mohan; Thaper, Rajesh Kumar; Kumar, Saridi Madhava Dileep; Sanwal, Sudhir Singh</li></ul>The present invention relates to a process for the direct preparation of malic acid salt of ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123511</guid>
			      </item>
<item>
			         <title><![CDATA[Process for the preparation of esters of 1-substituted-3-fluoroalkyl-pyrazole-4-carboxylic acids]]></title>
			         <link>http://www.patentstorm.us/applications/20130123510/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123510</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Jaunzems, Janis; Braun, Max Josef</li></ul>A process for the manufacture of an ester or the respective free acid of a 1-substituted-3-fluoroalkyl-pyrazole-4-carboxylic acid of formula (I), wherein in such formula (I), Y is H, F or an alkyl group having from 1 to 12 carbon atoms which is optionally substituted by at least one halogen atom, an aralkyl group or an aryl group; R<sub>1 </sub>is H or an organic residue; R<sub>2 </sub>is H or an organic residue. Such process comprises submitting a compound of formula (II) to a reduction ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123510</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE PREPARATION OF DIMIRACETAM]]></title>
			         <link>http://www.patentstorm.us/applications/20130123509/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123509</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Farina, Carlo; Roletto, Jacopo; Gobbato, Stefano</li></ul>The invention relates to a method of manufacture of dimiracetam (2,5-dioxohexahydro-1 H-pyrrolo[1,2-a]imidazole), characterized in that a 4-oxo-butanoic acid ester is condensed with glycinamide in a one-pot reaction with a controlled pH. The reaction may be performed in aqueous solution or in an anhydrous lower alcohol ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123509</guid>
			      </item>
<item>
			         <title><![CDATA[NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION]]></title>
			         <link>http://www.patentstorm.us/applications/20130123508/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123508</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Bretonniere, Yann; Andraud, Chantal; Buron, Wissam</li></ul>The present invention relates to heptamethine hemicyanine chromophores of formula (I): where R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, R<sub>4</sub>, R′<sub>4</sub>, R<sub>5</sub>, R′<sub>5</sub>, R<sub>6</sub>, R′<sub>6</sub>, R<sub>7</sub>, X, Y<sub>1 </sub>and Y<sub>2 </sub>are as defined in claim <b>1</b>, to the method for preparing same as well as to the use of such chromophores for the second-order nonlinear optical property ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123508</guid>
			      </item>
<item>
			         <title><![CDATA[BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20130123507/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123507</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;JIANGSU HENGRUI MEDICINE CO. LTD., ; LTD., SHANGHAI HENGRUI PHARMACEUTICAL CO.</li></ul>The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description.</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123507</guid>
			      </item>
<item>
			         <title><![CDATA[SUBSTITUTED ENAMINOCARBONYL COMPOUNDS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123506/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123506</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;BAYER CROPSCIENCE AG, </li></ul>The present invention relates to novel substituted enaminocarbonyl compounds, to processes for their preparation and to their use for controlling animal pests, especially arthropods, in particular ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123506</guid>
			      </item>
<item>
			         <title><![CDATA[ETHINYL-PYRAZOLE DERIVATIVE]]></title>
			         <link>http://www.patentstorm.us/applications/20130123500/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123500</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Konishi, Kazuhide; Yamamoto, Kanako; Matsuda, Yohei; Okada, Kumiko; Kawamoto, Hiroshi; Masuda, Seiji; Ohta, Hiroshi; Shibata, Tsuyoshi; Nakamura, Toshio; Yasuhara, Akito; Sakagami, Kazunari</li></ul>Provided is a novel compound represented by formula [I] or a pharmaceutically acceptable salt thereof having antagonistic activity against group II metabolism-type glutamic acid (m-Glu) receptors. The compound or pharmaceutically acceptable salt thereof is useful as a prophylactic or therapeutic agent for diseases such as new mood disorders (depressive and bipolar disorders), anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123500</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123493/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123493</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Learmonth, David Alexander; Broadbelt, Brian; Wahnon, Jorge Bruno Reis</li></ul>A process for preparing a substitute urea of Formula (II) or Formula (I), or a pharmaceutically acceptable salt or ester thereof, Formula (II): Formula (I): the process comprising the reaction of a carbamate of Formula (II′): or formula (I′): with a primary or secondary amine of the formula: R1R2NH, wherein ring A, and R1, R2, R5, V, W, X, Y and Z are as defined ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123493</guid>
			      </item>
<item>
			         <title><![CDATA[ACENAPHTHO HETEROCYCLIC COMPOUND AND APPLICATION THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20130123492/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123492</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Zhang, Zhichao; Wu, Guiye</li></ul>The present invention relates to acenaphtho heterocyclic compounds and their uses in manufacturing the BH3 mimetics as Bcl-2-like protein inhibitors. Structures are shown in the following:</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">Statistical analysis of their bio-activities showed these compounds exhibit better BH3 mimicking property than the reported compounds. These compounds can simulate BH3-only protein, competitively bind and antagonizing Bcl-2 and Mcl-1 proteins in ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123492</guid>
			      </item>
<item>
			         <title><![CDATA[CATIONIC LIPIDS, METHODS FOR PREPARING THE SAME, AND DELIVERY SYSTEMS HAVING ABILITY TO TRANSITION INTO CELLS COMPRISING THE SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130123485/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123485</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Park, Myung-Ok; Yoon, Eun Young</li></ul>The present invention provides cationic lipids, methods for preparing the same, and delivery systems comprising the same. The present invention can provide cationic lipids which enhance the efficiency of intracellular or in vivo delivery of multiple-anionic target compounds such as drugs, anticancer agents, nucleic acids, etc., have no intracellular toxicity, but show increased stability, methods for preparing the same, and delivery systems comprising the ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123485</guid>
			      </item>
<item>
			         <title><![CDATA[CRYSTALLINE RESIN COMPOSITION]]></title>
			         <link>http://www.patentstorm.us/applications/20130123397/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123397</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Ozawa, Masaaki; Hayashi, Hisato; Suwa, Takeshi</li></ul>It is an object to provide a nucleating agent that is suitable for promoting crystallization of a crystalline resin and is derived from a natural product, in order to improve the moldability and the heat resistance of crystalline resins such as a poly(lactic acid) resin and a polyolefin resin; and to provide a crystalline resin composition including the nucleating agent. There is provided a crystalline resin composition including a crystalline resin and an amino acid metal salt; and a ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123397</guid>
			      </item>
<item>
			         <title><![CDATA[NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20130123338/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123338</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Martin, Alan; Wood, Mark; Heyes, James</li></ul>The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses. In addition, the compositions ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123338</guid>
			      </item>
<item>
			         <title><![CDATA[FUNGICIDAL PYRAZOLES]]></title>
			         <link>http://www.patentstorm.us/applications/20130123323/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123323</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Kar, Moumita; Patel, Kanu Maganbhai</li></ul>Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof,</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">
    <ul id="ul0002" list-style="none">
        <li id="ul0002-0001" num="0000">Q<sup>1 </sup>is a phenyl ring, naphthalenyl ring system, a 5- to 6-membered fully unsaturated heterocyclic ring or an 8- to 10-membered heteroaromatic bicyclic ring ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123323</guid>
			      </item>
<item>
			         <title><![CDATA[BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123322/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123322</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Gary, Stephanie; Wachendorff-neumann, Ulrike; Desbordes, Philippe; Benting, Jurgen; Dahmen, Peter</li></ul>The present invention relates to fungicidal benzocycloalkene carboxamides or their thiocarboxamide derivatives of formula (I), their process of preparation and intermediate compounds for their preparation, their use as fungicides, particularly in the form of fungicidal compositions and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123322</guid>
			      </item>
<item>
			         <title><![CDATA[SUBSTITUTED IMIDAZOLONES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE]]></title>
			         <link>http://www.patentstorm.us/applications/20130123315/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123315</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;DeMong, Duane; Miller, Michael W.; Dai, Xing; Stamford, Andrew</li></ul>The present invention relates to compounds of the general structure shown in Formula (A): (A): and includes pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, and isomers of said compounds. Pharmaceutical compositions and methods of treatment are also included.</p>
<p id="p-0002" ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123315</guid>
			      </item>
<item>
			         <title><![CDATA[BENZOFURANONE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130123313/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123313</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Ohishi, Yoshitaka; Toda, Takao; Takeda, Seiichi</li></ul>Provided is a novel compound having an effective anti-cancer activity.</p>
<p id="p-0002" num="0000">The novel compound according to the present invention includes a compound represented by formula (I):</p>
<p id="p-0003" num="0000">
</p>
<p id="p-0004" num="0000">[wherein R<sup>1 </sup>represents an alkoxyalkyl group having 2 to 6 carbon atoms]
<br/>
or a pharmaceutically acceptable salt ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123313</guid>
			      </item>
<item>
			         <title><![CDATA[FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES]]></title>
			         <link>http://www.patentstorm.us/applications/20130123305/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123305</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Beier, Christian; Dubost, Christophe; Desbordes, Philippe; Genix, Pierre; Portz, Daniela; Bernier, David; Benting, Jurgen; Coqueron, Pierre-Yves; Wachendorff-Neumann, Ulrike; Gary, Stephanie</li></ul>The present invention relates to hydroximoyl-tetrazole derivatives of formula (I), their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein A represents a tetrazoyl group, Het represents a pyridyl group or a thiazolyl group and X represents various ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123305</guid>
			      </item>
<item>
			         <title><![CDATA[CONTROL AGENT FOR SOFT ROT AND CONTROL METHOD FOR THE SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130123287/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123287</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Sugimoto, Koji; Hayashi, Hiroyuki</li></ul>Providing a novel control agent for soft rot and a novel control method for the same. A compound having no antibacterial activity against <i>Erwinia carotovora </i>but having a control activity against fungi on soil surface, specifically containing, as the active ingredient, a fungicide comprising any of a strobilurin compound such as azoxystrobin and kresoxim-methyl, an azole compound such as triflumizol, cyazofamid, amisulbrom, and thiophanate-methyl, a carboxamide compound such as ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123287</guid>
			      </item>
<item>
			         <title><![CDATA[Compositions and Methods for Targeting A3G:RNA Complexes]]></title>
			         <link>http://www.patentstorm.us/applications/20130123285/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123285</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Prohaska, Kimberly; McDougall, William M.; Smith, Harold C.</li></ul>The present invention provides an assay for screening any agent that modulates the ability of A3G to bind with RNA. The invention provides an agent identified by high throughput screening methods and methods of treatment using the identified agent as a means of inhibiting HIV infection and reducing the emergence of viral ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123285</guid>
			      </item>
<item>
			         <title><![CDATA[HETEROCYCLIC COMPOUNDS USEFUL FOR KINASE INHIBITION]]></title>
			         <link>http://www.patentstorm.us/applications/20130123284/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123284</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Murphy, Eric A.; Arnold, Lee Daniel</li></ul>Provided herein are compounds useful for kinase ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123284</guid>
			      </item>
<item>
			         <title><![CDATA[COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM]]></title>
			         <link>http://www.patentstorm.us/applications/20130123265/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123265</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;King, Frank; Whitten, Jeffrey P.; Velicelebi, Gonul; Stauderman, Kenneth A.; Pei, Yazhong</li></ul>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases, disorders or conditions that would benefit from inhibition of SOC channel ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123265</guid>
			      </item>
<item>
			         <title><![CDATA[SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL-1, 3-DIHYDRO-INDOL-2-ONES AND DERIVATIVES THEREOF AS KINASE INHIBITORS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123259/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123259</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Allergan, Inc., </li></ul>The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123259</guid>
			      </item>
<item>
			         <title><![CDATA[2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof]]></title>
			         <link>http://www.patentstorm.us/applications/20130123252/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123252</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Shu, Lei; Zheng, Rui; Barnes, David; Cohen, Scott Louis; Fu, Jiping</li></ul>The present invention provides a compound of formula I:</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123252</guid>
			      </item>
<item>
			         <title><![CDATA[MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130123246/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123246</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Incyte Corporation, </li></ul>The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123246</guid>
			      </item>
<item>
			         <title><![CDATA[DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE]]></title>
			         <link>http://www.patentstorm.us/applications/20130123243/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123243</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Celtaxsys, Inc., </li></ul>This invention is directed to compounds of formula (I):</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">where r, q, R, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5a</sup>, R<sup>5b</sup>, R<sup>5c</sup>, R<sup>6a</sup>, R<sup>6b</sup>, R<sup>6c</sup>, R<sup>7</sup>, R<sup>8</sup>, and R<sup>9 </sup>are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123243</guid>
			      </item>
<item>
			         <title><![CDATA[COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123242/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123242</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Das, Sanjoy Kumar; Chan Chun Kong, Laval; Nguyen-Ba, Nghe; Pereira, Oswy Z.; Wang, Wuyi; Bedard, Jean; Reddy, Thumkunta Jagadeeswar; Siddiqui, Mohammad Arshad; Yannopoulos, Constantin G.</li></ul>The present invention provides novel compounds represented by formula I:</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123242</guid>
			      </item>
<item>
			         <title><![CDATA[SUBSTITUTED BENZYLSPIROINDOLIN-2-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1]]></title>
			         <link>http://www.patentstorm.us/applications/20130123236/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123236</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;VANDERBILT UNIVERSITY, </li></ul>In one aspect, the invention relates to substituted benzylspiroindolin-2-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M<sub>1 </sub>(mAChR M<sub>1</sub>); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123236</guid>
			      </item>
<item>
			         <title><![CDATA[Tricyclic Compounds and Methods of Making and Using Same]]></title>
			         <link>http://www.patentstorm.us/applications/20130123235/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123235</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Cramp, Susan Mary; Zahler, Robert; Clark, David; Dyke, Hazel Joan; Pallin, Thomas David</li></ul>The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123235</guid>
			      </item>
<item>
			         <title><![CDATA[INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES]]></title>
			         <link>http://www.patentstorm.us/applications/20130123225/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123225</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;North Carolina State University, </li></ul>Disclosure is provided for carbamate compounds that prevent, remove and/or inhibit the formation of biofilms, compositions including these compounds, devices including these compounds, and methods of using the ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123225</guid>
			      </item>
<item>
			         <title><![CDATA[TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE BENEFITS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123217/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123217</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Neumedics, </li></ul>The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123217</guid>
			      </item>
<item>
			         <title><![CDATA[CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20130123216/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123216</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;RADIORX, INC., C/O INTERWEST VENTURE PA, ; ALLIANT TECHSYSTEMS INC., </li></ul>The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123216</guid>
			      </item>
<item>
			         <title><![CDATA[2,5-DIOXOIMIDAZOLIDIN-1-YL-3-PHENYLUREA DERIVATIVES AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS]]></title>
			         <link>http://www.patentstorm.us/applications/20130123215/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130123215</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Allergan, Inc., </li></ul>The present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) ...<br />]]></description>		         
			         <guid isPermaLink="false">20130123215</guid>
			      </item>
<item>
			         <title><![CDATA[PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVE METHODS]]></title>
			         <link>http://www.patentstorm.us/applications/20130122276/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130122276</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;FUJIFILM Corporation, </li></ul>A photoelectric conversion device comprising a transparent electrically conductive film, a photoelectric conversion film and an electrically conductive film in this order, wherein the photoelectric conversion film comprises a photoelectric conversion layer, and an electron blocking layer, wherein the electron blocking layer contains a compound represented by the specific ...<br />]]></description>		         
			         <guid isPermaLink="false">20130122276</guid>
			      </item>
<item>
			         <title><![CDATA[Derivatized Hyperbranched Polyglycerols]]></title>
			         <link>http://www.patentstorm.us/applications/20130122112/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130122112</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Brooks, Donald; Kizhakkedathu, Jayachandran; Ye, Lu; Mugabe, Clement; So, Alan; Kainthan, Rajesh Kumar; Burt, Helen M.; Guan, Dechi; Liggins, Richard; Jackson, John K.; Gleave, Martin E.</li></ul>Herein are provided derivatized hyperbranched polyglycerols (“dHPGs”). The dHPG comprises a core comprising a hyperbranched polyglycerol derivatized with C<sub>1</sub>C<sub>20 </sub>alkyl chains and a shell comprising at least one hydrophilic substituent bound to hydroxyl groups of the core, wherein the hyperbranched polyglycerol comprises from about 1 to about 200 moles of the at least one hydrophilic substituent. The dHPGs are for use as agents for the delivery of a drug or other ...<br />]]></description>		         
			         <guid isPermaLink="false">20130122112</guid>
			      </item>
<item>
			         <title><![CDATA[Hepatitis C Virus Inhibitors]]></title>
			         <link>http://www.patentstorm.us/applications/20130121957/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130121957</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Lopez, Omar D.; Bender, John A.; Belema, Makonen; Nguyen, Van N.; Kadow, John F.; Meanwell, Nicholas A.; Chen, Qi; Wang, Gan</li></ul>The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV ...<br />]]></description>		         
			         <guid isPermaLink="false">20130121957</guid>
			      </item>
<item>
			         <title><![CDATA[DYE COMPOSITIONS AND DYE SYNTHESES]]></title>
			         <link>http://www.patentstorm.us/applications/20130121926/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130121926</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Balaji, Srinath; Johansen, John Henrik; Achanath, Radha</li></ul>The present invention relates to sulfonated optical dye compositions, especially dyes suitable for biological applications in vitro, and for in vivo imaging. Improved dye compositions and intermediates are provided, which enable the suppression of undesirable newly-identified impurities. Also provided is the use of the improved dye compositions in the preparation of conjugates with biological targeting ...<br />]]></description>		         
			         <guid isPermaLink="false">20130121926</guid>
			      </item>
<item>
			         <title><![CDATA[HIGHLY EFFICIENT CARBAZOLE-BASED COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130119367/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130119367</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Lee, Jun Yeob; Jeon, Soon Ok; Son, Hyo Suk; Yook, Kyoung Soo; Jang, Sang Eok</li></ul>The present invention relates to a highly efficient carbazole-based compound and to an organic electroluminescence device including the same. According to the present invention, provided are a compound for an organic electroluminescence device and an organic electroluminescence device including the compound, in which a carbazole-based phosphine oxide compound, which is a compound intended for an organic electroluminescence device, is employed to overcome the problems of conventional compounds ...<br />]]></description>		         
			         <guid isPermaLink="false">20130119367</guid>
			      </item>
<item>
			         <title><![CDATA[PHENYL AND FLUORENYL SUBSTITUTED PHENYL-PYRAZOLE COMPLEXES OF Ir]]></title>
			         <link>http://www.patentstorm.us/applications/20130119361/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130119361</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;The University of Southern California, </li></ul>The invention provides emissive materials and organic light emitting devices using the emissive materials in an emissive layer disposed between and electrically connected to an anode and a cathode. The emissive materials include compounds with the following structure:</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein at least one of R<sub>8 </sub>to R<sub>14 </sub>is phenyl or substituted phenyl, and/or at least two of R<sub>8 </sub>to R<sub>14 </sub>that are adjacent are ...<br />]]></description>		         
			         <guid isPermaLink="false">20130119361</guid>
			      </item>
<item>
			         <title><![CDATA[ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME]]></title>
			         <link>http://www.patentstorm.us/applications/20130119360/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130119360</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;KATAKURA, Rie; KATOH, Eisaku; SUGINO, Motoaki; FUJISAWA, Rie; SUGITA, Shuichi</li></ul>Disclosed is an organic electroluminescence element comprising an anode, a cathode and a plurality of organic compound layers between the anode and the cathode, provided that one of the organic compound layers is a light emitting layer containing a phosphorescence emitting compound,
<ul id="ul0001" list-style="none">
    <li id="ul0001-0001" num="0000">
    <ul id="ul0002" list-style="none">
        <li id="ul0002-0001" num="0000">wherein at least one of the organic compound layers contains a ...<br />]]></description>		         
			         <guid isPermaLink="false">20130119360</guid>
			      </item>
<item>
			         <title><![CDATA[STYRYL-BASED COMPOUND, COMPOSITION CONTAINING STYRYL-BASED COMPOUND, AND ORGANIC LIGHT EMITTING DIODE INCLUDING STYRYL-BASED COMPOUND]]></title>
			         <link>http://www.patentstorm.us/applications/20130119355/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130119355</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Kim, Young-Kook; Hwang, Seok-Hwan; Jung, Hye-Jin; Lim, Jin-O; Lee, Jong-Hyuk; Shin, Dae-Yup; Han, Sang-Hyun; Kim, Soo-Yon</li></ul>A styryl-based compound represented by Formula 1, a composition containing the styryl-based compound, and an organic light-emitting diode (OLED) including the styryl-based compound:</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">The styryl-based compound may exhibit high heat resistance and thus an OLED including the same may have low driving voltage, high brightness, high efficiency, and long ...<br />]]></description>		         
			         <guid isPermaLink="false">20130119355</guid>
			      </item>
<item>
			         <title><![CDATA[TRIPHENYLENE SILANE HOSTS]]></title>
			         <link>http://www.patentstorm.us/applications/20130119353/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130119353</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Kottas, Gregg; Dyatkin, Alexey; Zeng, Lichang</li></ul>Novel aryl silicon and aryl germanium host materials, and in particular host materials containing triphenylene and pyrene fragments, are described. These compounds improve OLED device performance when used as hosts in the emissive layer of the ...<br />]]></description>		         
			         <guid isPermaLink="false">20130119353</guid>
			      </item>
<item>
			         <title><![CDATA[DYE FOR PHOTOELECTRIC CONVERSION, SEMICONDUCTOR ELECTRODE, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND NOVEL PYRROLINE-BASED COMPOUND]]></title>
			         <link>http://www.patentstorm.us/applications/20130118570/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130118570</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Maeda, Katsumi; Nakamura, Shin; Nakahara, Kentaro</li></ul>Provided is a dye for photoelectric conversion containing at least one or more kind of a compound represented by the following General Formula (1) (in Formula (1), R<sup>1 </sup>and R<sup>2 </sup>represent any one of —CN, —SO<sub>2</sub>R, —COOR, and —CONR<sub>2 </sub>(R represents a hydrogen atom, a substituted or unsubstituted alkyl group, a cycloalkyl group, or an aryl group); R<sup>3 </sup>represents a direct bond or a substituted or unsubstituted alkylene group; X represents an ...<br />]]></description>		         
			         <guid isPermaLink="false">20130118570</guid>
			      </item>
<item>
			         <title><![CDATA[METHODS AND SYSTEMS RELATING TO THE SELECTION OF SUBSTRATES COMPRISING CRYSTALLINE TEMPLATES FOR THE CONTROLLED CRYSTALLIZATION OF MOLECULAR SPECIES]]></title>
			         <link>http://www.patentstorm.us/applications/20130118399/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130118399</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventor:</strong> &nbsp;Massachusetts Institute of Technology, </li></ul>The present invention generally relates to methods and systems relating to the selection of substrates comprising crystalline templates for the controlled crystallization of molecular species. In some embodiments, the methods and systems allow for the controlled crystallization of a molecular species in a selected polymorphic form. In some embodiments, the molecular species is a small organic molecule (e.g., pharmaceutically active ...<br />]]></description>		         
			         <guid isPermaLink="false">20130118399</guid>
			      </item>
<item>
			         <title><![CDATA[METAL FREE BLEACHING COMPOSITION]]></title>
			         <link>http://www.patentstorm.us/applications/20130117941/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130117941</li><li><strong>Publication Date:</strong> &nbsp;2013-05-16</li><li><strong>Inventors:</strong> &nbsp;Rohwer, Hauke; Wendeborn, Frédérique; Hazenkamp, Menno; Frey, Markus</li></ul>The present invention relates to the use of a composition comprising specific a-amino-ketones, H<sub>2</sub>O<sub>2</sub>, a H<sub>2</sub>O<sub>2 </sub>precursor or a peracid and optionally an activator as a bleaching mixture for textile materials or dishes either manually or in an automatic washing machine or dish washer. Further aspects of the invention are the composition comprising specific a-aminoketones and H<sub>2</sub>O<sub>2</sub>, a H<sub>2</sub>O<sub>2 </sub>precursor or a peracid ...<br />]]></description>		         
			         <guid isPermaLink="false">20130117941</guid>
			      </item>
<item>
			         <title><![CDATA[FUNCTIONALIZED NON-PHENOLIC AMINO ACIDS AND ABSORBABLE POLYMERS THEREFROM]]></title>
			         <link>http://www.patentstorm.us/applications/20130116446/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130116446</li><li><strong>Publication Date:</strong> &nbsp;2013-05-09</li><li><strong>Inventor:</strong> &nbsp;Bezwada Biomedical, LLC, </li></ul>The present invention relates to compound of formula I, which are functionalized, non-phenolic amino acids, and polymers formed from the same.</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">Polymers formed from the functionalized amino acids are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical ...<br />]]></description>		         
			         <guid isPermaLink="false">20130116446</guid>
			      </item>
<item>
			         <title><![CDATA[TRIAZOLIUM CARBENE CATALYSTS AND PROCESSES FOR ASYMMETRIC CARBON-CARBON BOND FORMATION]]></title>
			         <link>http://www.patentstorm.us/applications/20130116445/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130116445</li><li><strong>Publication Date:</strong> &nbsp;2013-05-09</li><li><strong>Inventors:</strong> &nbsp;Dirocco, Daniel; Guiles, Joseph; Rovis, Tomislav</li></ul>Provided herein are chiral triazolium catalysts useful for asymmetric C—C bond formation and processes for their preparation. Also provided are synthetic reactions in which these catalysts are used, in particular, in asymmetric C—C bond ...<br />]]></description>		         
			         <guid isPermaLink="false">20130116445</guid>
			      </item>
<item>
			         <title><![CDATA[PROCESS FOR CABAZITAXEL, AND INTERMEDIATES THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20130116444/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20130116444</li><li><strong>Publication Date:</strong> &nbsp;2013-05-09</li><li><strong>Inventor:</strong> &nbsp;Scinopharm Taiwan, LTD., </li></ul>The present invention relates to processes for making cabazitaxel, cabazitaxel analogues and intermediates thereof. The invention provides novel compounds useful in the synthesis of ...<br />]]></description>		         
			         <guid isPermaLink="false">20130116444</guid>
			      </item>
</channel>
		</rss>